Prime Medicine, Inc. (PRME)
(Real Time Quote from BATS)
$6.60 USD
+0.18 (2.80%)
Updated May 14, 2024 02:01 PM ET
2-Buy of 5 2
D Value C Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -0.45 |
EPS Last Quarter | -0.44 |
Last EPS Surprise | 2.22% |
ABR | 1.73 |
Earnings ESP
|
3.37% |
---|---|
Current Year | -1.80 |
Next Year | -1.61 |
EPS (TTM) | -2.02 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.45 | -0.45 | -1.80 | -1.61 |
# of Estimates | 4 | 4 | 6 | 6 |
Most Recent Consensus | -0.45 | -0.46 | -1.77 | -1.71 |
High Estimate | -0.37 | -0.34 | -1.46 | -1.13 |
Low Estimate | -0.49 | -0.49 | -2.18 | -2.01 |
Year ago EPS | -0.47 | -0.55 | -2.03 | -1.80 |
Year over Year Growth Est. | 4.26% | 18.18% | 11.33% | 10.28% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.45 | -0.45 | -1.80 | -1.61 |
7 Days Ago | -0.44 | -0.45 | -1.80 | -1.65 |
30 Days Ago | -0.44 | -0.45 | -1.80 | -1.65 |
60 Days Ago | -0.44 | -0.45 | -1.83 | -1.61 |
90 Days Ago | -0.49 | -0.49 | -1.88 | -1.86 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.43 | -0.42 | -1.71 | -1.36 |
Zacks Consensus Estimate | -0.45 | -0.45 | -1.80 | -1.61 |
Earnings ESP | 3.37% | 6.74% | 5.01% | 15.84% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.44 | -0.56 | -0.55 | -0.47 | NA |
Estimate | -0.45 | -0.48 | -0.45 | -0.42 | NA |
Difference | 0.01 | -0.08 | -0.10 | -0.05 | -0.06 |
Surprise | 2.22% | -16.67% | -22.22% | -11.90% | -12.14% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more